myMatrixx Senior VP of Product Development Talks COVID-19 and Workers' Comp with R & I

Posted on February 11, 2021 by myMatrixx
Pharmacy Image COVID-19 myMatrixx

It’s been more than a year since the first confirmed cases of COVID-19 in the United States, and yet much uncertainty remains around the long-term effects of the virus on the workforce. Recently, Hollie Lamboy, Senior Vice President of Product Development for myMatrixx, explored this and other ideas in a Q&A for Risk & Insurance. In the interview, Lamboy covers everything from the importance of focusing on behavioral health to changes in the rate of new claims. 

Throughout a variety of topics, one common theme is the importance of responding to uncertainty with an evidence-based approach. As myMatrixx develops new products and solutions, whether to manage the pandemic or other ongoing concerns in workers’ comp, Lamboy stresses the importance of sound clinical evidence backed by data. 

Read Full Article